CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: For the final experiments, FFPE BM samples from HDs and CP-CML patients were subjected to consecutive immunostaining for CD45RA, CD34, IRF8, MPO, CD66b and α-defensins (DEFAs) to identify NCPs.